By Shubham Kalia
April 8 (Reuters) - The U.S. government will allocate nearly 85% fewer Johnson & Johnson JNJ.N COVID-19 vaccines next week to non-pharmacy providers, data from the federal Centers for Disease Control and Prevention (CDC) showed.
Allocations will fall to 785,500 doses from 4.95 million doses this week. The data does not include a federal retail pharmacy program.
An official from the U.S. Department of Health and Human Services (HHS), who did not wish to be named, told Reuters that J&J released about 1.5 million doses to the U.S. government this week, compared with about 11 million doses last week. The allocation and distribution of COVID-19 vaccines is done by the federal government.
The official said HHS expects J&J's supply to be uneven, but the company had assured it was on track to meet its commitment of near 100 million doses by the end of May.